文献速递流行病学与生物统计

中心性肥胖指标与全因死亡风险:72项前瞻性队列研究的系统综述与剂量反应荟萃分析

Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies.
PubMed 文献 · BMJ · 2020-09-23

该研究系统检索并荟萃分析了72项前瞻性队列研究、共2 528 297名参与者,评估腰围、臀围、大腿围、腰臀比、腰高比等中心性肥胖指标与全因死亡风险的关联。结果显示腰围、腰臀比、腰高比、腰腿比、身体脂肪指数及A体型指数均与全因死亡风险正相关,且独立于体质指数;较大的臀围和大腿围则与较低风险相关。

要点

  • 腰围每增加10 cm,全因死亡风险HR为1.11(95%CI 1.08–1.13)。
  • 腰臀比每增加0.1单位,全因死亡风险HR为1.20(95%CI 1.15–1.25)。
  • 臀围每增加10 cm,全因死亡风险HR为0.90(95%CI 0.81–0.99)。

核心结论

  • 腰围、腰臀比、腰高比、腰腿比、身体脂肪指数和A体型指数等中心性肥胖指标独立于整体肥胖,与全因死亡风险显著正相关。
  • 较大的臀围和大腿围与较低的全因死亡风险相关。
  • 中心性肥胖指标可与体质指数联合作为判断早死风险的补充方法。

研究设计与样本

  • 系统综述与剂量反应荟萃分析,检索PubMed和Scopus自建库至2019年7月及相关参考文献。
  • 最终纳入72项前瞻性队列研究,共2 528 297名参与者。
  • 采用随机效应剂量反应荟萃分析评估线性趋势,并采用一步线性混合效应荟萃分析估计剂量反应曲线。

主要发现

  • 腰围(增加10 cm)的汇总HR为1.11(95%CI 1.08–1.13,I²=88%,n=50)。
  • 臀围(增加10 cm)的汇总HR为0.90(95%CI 0.81–0.99,I²=95%,n=9)。
  • 大腿围(增加5 cm)的汇总HR为0.82(95%CI 0.75–0.89,I²=54%,n=3)。
  • 腰臀比(增加0.1单位)的汇总HR为1.20(95%CI 1.15–1.25,I²=90%,n=31)。
  • 腰高比(增加0.1单位)的汇总HR为1.24(95%CI 1.12–1.36,I²=94%,n=11)。

关键数值与推荐

  • 腰腿比(增加0.1单位)的汇总HR为1.21(95%CI 1.03–1.39,I²=97%,n=2)。
  • 身体脂肪指数(增加10%)的汇总HR为1.17(95%CI 1.00–1.33,I²=75%,n=4)。
  • A体型指数(增加0.005单位)的汇总HR为1.15(95%CI 1.10–1.20,I²=87%,n=9)。
  • 腰围和腰高比与全因死亡风险在男女中均呈近似J形关联;腰臀比和A体型指数呈正向单调关联;身体脂肪指数呈U形关联。

临床怎么用

  • 在临床和人群风险评估中,可将腰围、腰臀比、腰高比等中心性肥胖指标与体质指数联合使用,以补充判断早死风险。
  • 关注中心性脂肪分布,而不仅依赖体质指数评估肥胖相关死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To quantify the association of indices of central obesity, including waist circumference, hip circumference, thigh circumference, waist-to-hip ratio, waist-to-height ratio, waist-to-thigh ratio, body adiposity index, and A body shape index, with the risk of all cause mortality in the general population, and to clarify the shape of the dose-response relations. DESIGN: Systematic review and meta-analysis. DATA SOURCES: PubMed and Scopus from inception to July 2019, and the reference lists of all related articles and reviews. ELIGIBILITY CRITERIA FOR SELECTING STUDIES: Prospective cohort studies reporting the risk estimates of all cause mortality across at least three categories of indices of central fatness. Studies that reported continuous estimation of the associations were also included. DATA SYNTHESIS: A random effects dose-response meta-analysis was conducted to assess linear trend estimations. A one stage linear mixed effects meta-analysis was used for estimating dose-response curves. RESULTS: Of 98 745 studies screened, 1950 full texts were fully reviewed for eligibility. The final analyses consisted of 72 prospective cohort studies with 2 528 297 participants. The summary hazard ratios were as follows: waist circumference (10 cm, 3.94 inch increase): 1.11 (95% confidence interval 1.08 to 1.13, I2=88%, n=50); hip circumference (10 cm, 3.94 inch increase): 0.90 (0.81 to 0.99, I2=95%, n=9); thigh circumference (5 cm, 1.97 inch increase): 0.82 (0.75 to 0.89, I2=54%, n=3); waist-to-hip ratio (0.1 unit increase): 1.20 (1.15 to 1.25, I2=90%, n=31); waist-to-height ratio (0.1 unit increase): 1.24 (1.12 to 1.36, I2=94%, n=11); waist-to-thigh ratio (0.1 unit increase): 1.21 (1.03 to 1.39, I2=97%, n=2); body adiposity index (10% increase): 1.17 (1.00 to 1.33, I2=75%, n=4); and A body shape index (0.005 unit increase): 1.15 (1.10 to 1.20, I2=87%, n=9). Positive associations persisted after accounting for body mass index. A nearly J shaped association was found between waist circumference and waist-to-height ratio and the risk of all cause mortality in men and women. A positive monotonic association was observed for waist-to-hip ratio and A body shape index. The association was U shaped for body adiposity index. CONCLUSIONS: Indices of central fatness including waist circumference, waist-to-hip ratio, waist-to-height ratio, waist-to-thigh ratio, body adiposity index, and A body shape index, independent of overall adiposity, were positively and significantly associated with a higher all cause mortality risk. Larger hip circumference and thigh circumference were associated with a lower risk. The results suggest that measures of central adiposity could be used with body mass index as a supplementary approach to determine the risk of premature death.

来源:BMJ,查看原文。版权归原作者所有。

引用

  1. Jayedi A, Soltani S, Zargar MS, et al. Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies. BMJ. 2020. PMID: 32967840. doi:10.1136/bmj.m3324

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。